|
| |
Image Results
Loading...
Loading...
RAPAFLO Pages on BioPortfolio:
|
BioPortfolio - Watson Pharmaceuticals, Inc. - RAPAFLO(TM ...
8 May 2009 ... Read RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic ... ( http://www.bioportfolio.com/news/RAPAFLO(TM)_(silodosin) ...
http://www.bioportfolio.com/news/RAPAFLO(TM)_(silodosin)_Pro...
|
BioPortfolio - Watson Pharmaceuticals, Inc. - Watson Announces ...
Read Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in ... RAPAFLO(TM) (silodosin), a Novel New Treatment ...
http://www.bioportfolio.com/news/Watson_Announces_United_Sta...
|
BioPortfolio - Kissei Pharmaceutical Co., Ltd
RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic ... Watson Announces United States Availability of RAPAFLO(TM) (silodosin), ...
http://www.bioportfolio.com/biocorporate/25317-Kissei_Pharma...
|
BioPortfolio - Retrograde Obturation
Presented Data Confirm That RAPAFLO(TM) (silodosin) Provides Rapid, Highly Effective, Symptom Relief for Benign Prostatic Hyperplasia (BPH) Patients ...
http://www.bioportfolio.com/indepth/Retrograde_Obturation.ht...
|
BioPortfolio News: Watson Pharmaceuticals, Inc. - Watson Reports ...
Brand product sales for the third quarter of 2009 increased slightly to $96.1 million, due primarily to sales of new products, including Rapaflo® and ...
http://www.bioportfolio.com/news/Watson-Reports-Third-Quarte...
|
BioPortfolio News: Watson Pharmaceuticals, Inc. - Watson ...
This decline was offset in part by the launch of new products Gelnique(TM) and Rapaflo(TM). Brand other revenue increased $1.2 million to $17.7 million. ...
http://www.bioportfolio.com/news/Watson_Pharmaceuticals_Repo...
|
BioPortfolio - BioPortfolio News 2009-05-08
07:50: RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia ... http://www.bioportfolio.com/news/RAPAFLO%28TM%29_%28silodosin%
...
http://www.bioportfolio.com/news/2009-05-08.html...
| Results from other life science and pharmaceutical sites:
FDA Approves Rapaflo for the Treatment of Symptoms Due to an ...
10 Oct 2008 ... The US Food and Drug Administration today approved Rapaflo (silodosin) capsules for the treatment of symptoms due to benign prostatic ...
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/20...
|
DailyMed: About DailyMed
RAPAFLO, an alpha-1 adrenergic receptor antagonist, is indicated for the treatment ..... RAPAFLO is the brand name for silodosin, a selective antagonist
of ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=12403...
|
Watson Pharmaceuticals, Inc. Release: RAPAFLO(TM) (silodosin ...
11 May 2009 ... RAPAFLO(TM) was developed and is manufactured by Watson Pharmaceuticals, a leader in generic and specialty branded pharmaceuticals. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=139260...
|
Silodosin (Rapaflo) for benign prostatic hyperplasia.
12 Jan 2009 ... Silodosin (Rapaflo) for benign prostatic hyperplasia. [No authors listed]. Another alpha1a blocker that claims to be more than just another ...
http://www.ncbi.nlm.nih.gov/pubmed/19122568...
|
Watson Pharmaceuticals, Inc. Presented Data Confirm That RAPAFLO ...
29 Apr 2009 ... RAPAFLO(TM) is a new, uniquely selective alpha blocker for the treatment of the signs and symptoms of BPH, launched earlier this month by ...
http://www.biospace.com/news_story.aspx?NewsEntityId=137198...
|
New drug information: Rapaflo.
1: JAAPA. 2009 Jul;22(7):12. New drug information: Rapaflo. [No authors listed]. PMID: 19697564 [PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/19697564...
|
Watson Pharmaceuticals, Inc. Receives US FDA Approval for RAPAFLO ...
9 Oct 2008 ... "RAPAFLO's approval is the most important milestone for the Company's Brand division thus far," said Paul Bisaro, Chief Executive Officer of ...
http://www.biospace.com/news_story.aspx?NewsEntityId=112418...
|
Benign Prostatic Hyperplasia (BPH) Agents - Pharmacy Clinical ...
NOTE: Avodart, Flomax, Rapaflo and Uroxatral do not require ... Cardura XL, Proscar and Rapaflo are currently listed on the Aetna Formulary Exclusions List.
...
http://www.aetna.com/products/rxnonmedicare/data/2009/GU2009...
|
Silodosin - Wikipedia, the free encyclopedia
23 Sep 2009 ... silodosin has been accepted for filing. FDA approved this drug on October 9th, 2008. Silodosin is marketed under the tradename Rapaflo. ...
http://en.wikipedia.org/wiki/Silodosin...
|
Benign Prostatic Hyperplasia (BPH) Agents - Pharmacy Clinical ...
NOTE: Avodart, Flomax, Rapaflo, tamsulosin and Uroxatral do not require .... Abramowicz M. Silodosin (Rapaflo) for benign prostatic hyperplasia. ...
http://www.aetna.com/products/rxnonmedicare/data/2010/GU2010...
|
|
